Stephen W. Kaldor, Director at Furiex Pharmaceuticals, Inc. (FURX), sold 8,000 shares at $41.74 ($330K) on 2013-03-11, disclosed to the SEC on 2013-03-14.
Open-market sale of $330k FURX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.74 | 5,379 | $225K | 68.0% |
| 2 | $40.71 | 973 | $40K | 12.0% |
| 3 | $39.96 | 1,648 | $66K | 20.0% |
| Total | $41.25 avg | 8,000 | $330K | 100% |